News & Articles

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

The test results are designed to enable differential diagnosis in under 2.5 hours

Recent funding from the BARDA award helped the company accelerate development and validation

In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development

New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19

The scientific community is working at full speed to fight the severe acute respiratory syndrome

The rapid delivery program is designed to provide critical laboratory equipment in this time of need

Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies

OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19

Coronavirus is said to be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, which distinguishes it from influenza

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic